Tenaya Therapeutics, Inc. - TNYA
About Gravity Analytica
Recent News
- 04.24.2025 - Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
- 04.24.2025 - Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025
- 03.31.2025 - Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting
- 03.31.2025 - Tenaya Therapeutics Announces Late Breaker Presentation of New Data from MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 at American College of Cardiology Annual Meeting
- 03.24.2025 - Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
- 03.24.2025 - Tenaya Therapeutics Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models
- 03.19.2025 - Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session
- 03.19.2025 - Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session
- 03.12.2025 - March 12, 2025 8:40 AM EDT - March 12, 2025 9:10 AM EDT : Leerink Partners Global Healthcare Conference 2025
- 03.12.2025 - March 12, 2025 8:40 AM EDT - March 12, 2025 9:10 AM EDT : Leerink Partners Global Healthcare Conference 2025
Recent Filings
- 04.18.2025 - 8-K Current report
- 04.17.2025 - ARS Annual Report to Security Holders
- 04.17.2025 - DEF 14A Other definitive proxy statements
- 04.17.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
- 03.31.2025 - EFFECT Notice of Effectiveness
- 03.28.2025 - 8-K Current report
- 03.21.2025 - S-3 Registration statement under Securities Act of 1933
- 03.10.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]